Eurxsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-03-30
Share capital
1 001 000,00 PLN
Activity description

Eurx is a biotechnology company based in Gdańsk that specializes in the production of high-quality reagents for the scientific community. They offer a range of products including onTaq DNA Polymerase, various types of PCR tubes, and the Luciferase Perfect Rainbow Protein Ladder. With over 20 years of experience, Eurx emphasizes strict quality control and continuous development of their product offerings.

Registered address
Przyrodników 3, 80-297 Gdańsk, Poland
Website
eurx.com.plWebsite active
Email
Email warning
Phone
Electronic delivery address
AE:PL-53459-62335-SDBIH-16

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.64mMedianUSD 72.15kAverageUSD 3.22m
Net profit
This companyUSD -263.73kMedianUSD 87.69AverageUSD 112.20k
Operating costs
This companyUSD 1.88mMedianUSD 75.02kAverageUSD 3.02m
Assets
This companyUSD 1.15mMedianUSD 121.49kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2003-01-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

244 tenders recorded as contractor: 162 national ($1,288,363) and 82 EU ($29,381,434).

SubjectAmount
Dostawa odczynników
—
DZP.242.246.2026. Sukcesywna dostawa odczynników, kontroli i materiałów zużywalnych dla Laboratoriów Analitycznych (3 obszary) z dzierżawą aparatów na 24 miesiące.
—
Dostawa odczynników chemicznych
—

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Renata Harasimowicz Słowińska — Vice President of the Management Board
Peter Joseph Smyczek — President of the Management Board
Sylwia Maria Rutkowska — Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly are authorised to make declarations and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
Smyczek International Holdings i Llc
9,932$268,287.4199.2208%
Others
78$2,106.970.7792%

Beneficial owners

Person
Peter Joseph Smyczek (78)

Competitors

Name
Scope FluidicsS.A.
Read-GeneS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
RDLSsp. z o.o.
Aurevia Polandsp. z o.o.
COS LabP.S.A.
RS2 Europesp. z o.o.
MPR Labssp. z o.o.
GenxoneS.A.

Change history

DateEvent
2021-03-03PKD change
2010-05-20PKD change
2007-01-10Share capital change
2006-02-03PKD change
2005-12-13Address change

FAQ

Last updated: 2026-07-20